000 01651 a2200469 4500
005 20250516080400.0
264 0 _c20120501
008 201205s 0 0 eng d
022 _a1872-9142
024 7 _a10.1016/j.molimm.2012.01.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiberman, Ana C
245 0 0 _aUnderlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death.
_h[electronic resource]
260 _bMolecular immunology
_cApr 2012
300 _a220-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBlotting, Western
650 0 4 _aCell Death
650 0 4 _aCell Separation
650 0 4 _aCyclic AMP
_ximmunology
650 0 4 _aFas Ligand Protein
_xbiosynthesis
650 0 4 _aFlow Cytometry
650 0 4 _aGlucocorticoids
_ximmunology
650 0 4 _aHumans
650 0 4 _aHybridomas
650 0 4 _aJurkat Cells
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMice
650 0 4 _aPromoter Regions, Genetic
_xgenetics
650 0 4 _aReceptors, Antigen, T-Cell
_xdrug effects
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSignal Transduction
_xgenetics
650 0 4 _aTransfection
700 1 _aRefojo, Damian
700 1 _aAntunica-Noguerol, Maria
700 1 _aHolsboer, Florian
700 1 _aArzt, Eduardo
773 0 _tMolecular immunology
_gvol. 50
_gno. 4
_gp. 220-35
856 4 0 _uhttps://doi.org/10.1016/j.molimm.2012.01.008
_zAvailable from publisher's website
999 _c21552233
_d21552233